HLA-C and neoplasm: Tumor-specific peptides are defined as neoantigens when they displayed by the major histocompatibility complex (MHC) on the surface of tumor cells, which can trigger a T-cell-mediated cytotoxic anti-tumor immune response and cause T-cell population expansion [9, 10].